| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, General Counsel And Sec
1 company
Sandercock Colin serves as a SVP, General Counsel And Sec at CUE. Across recent SEC filings that breaks down to 2 buys and 3 sells. Those positions are worth an estimated $824K at current prices.
The biggest single holding is CUE (~$824K) as SVP, General Counsel And Sec. The recent filings there lean toward selling, a net 2,962 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2020 | CUE Cue Biopharma, Inc. | SVP, General Counsel And Sec | Sale+OE | 13,274 | $20.00 | $265,480.00 | -43.7% | |
| Aug 4, 2020 | CUE Cue Biopharma, Inc. | SVP, General Counsel And Sec | Sale+OE | 6,626 | $20.00 | $132,530.05 | -16.2% | |
| Jun 10, 2019 | CUE Cue Biopharma, Inc. | SVP, General Counsel And Sec | Buy | 16,938 | $7.83 | $132,658.34 | +846.9% |